September 1997 – July 2002
Bachelor’s Degree: Hubei University of Medicine (formerly Yunyang Medical College), Anesthesiology
September 2006 – December 2009
Master’s Degree: Wenzhou Medical University, Anesthesiology
September 2015 – July 2018
Doctoral Degree: Soochow University, Anesthesiology
September 2023-Present
Member of the Party Committee, Deputy Director, Principal Investigator/Oujiang Laboratory
Deputy Director, Science and Technology Department/Wenzhou Medical University
Vice Chairman/Wenzhou Association for Science and Technology (Part-time)
Chief Physician/The First Affiliated Hospital of Wenzhou Medical University
May 2020-September 2023
Vice Chairman/Wenzhou Association for Science and Technology(Full-time)
Professor/ Wenzhou Medical University
Director, Division of Academic Planning and Science & Technology/The First Affiliated Hospital of Wenzhou Medical University
December 2019- May 2020
Deputy Director, Division of Science and Education/The First Affiliated Hospital of Wenzhou Medical University
December 2016-December 2019
Associate Professor, Associate Chief Physician/The First Affiliated Hospital of Wenzhou Medical University
December 2014-December 2016
Associate Chief Physician/The First Affiliated Hospital of Wenzhou Medical University
December 2009-December 2014
Attending Physician/The First Affiliated Hospital of Wenzhou Medical University
August 2002-December 2009
Physician/The First Affiliated Hospital of Wenzhou Medical University
Professor Geng Wujun and his research team focus on the following research areas:
(1) Post-stroke central pain (CPSP): investigating the neural circuits associated with CPSP-related negative emotions and identifying potential therapeutic targets;
(2) Ischemic stroke reperfusion injury: studying the regulation of pathological cascades and mechanisms of neurological recovery, with particular emphasis on the neuroprotective effects of electroacupuncture;
(3) Chronic pain disorders: exploring novel therapeutic strategies for conditions such as complex regional pain syndrome, phantom limb pain, and knee joint pain through physical therapy and fibroblast growth factor (FGF)-based interventions;
(4) Neurotechnology and translational research: developing AI-based dual-modal screening devices (integrating eye-tracking and speech analysis) for post-stroke depression, as well as designing pH-sensitive targeted drug delivery systems for ischemic stroke.
1. First Prize for Science and Technology Progress of the Ministry of Education of China (3/12), 2021
2. Third Prize of Zhejiang Provincial Science and Technology Progress Award (1/7), 2024
3. People’s Physician Award (Pain Medicine), 2023
4. Top Ten Outstanding Youth of Wenzhou, 2022
5. Chief Science Communication Expert, Zhejiang Province, 2025
6. Wenzhou Outstanding Science Communicator of the Year, 2024
7. Silver Medal, Geneva International Invention Exhibition, 2024
8. Zhejiang Provincial Science and Technology Achievement Award-Popularization Nomination, 2023
9. The Eighth “Best Mentor” Award of Wenzhou Medical University Graduate Students, 2025
Projects
1. National Natural Science Foundation of China (NSFC) - General Program: "Mechanism of Electroacupuncture-Induced Cerebral Ischemic Tolerance Mediated by Adipocyte-Derived Exosomal miRNA-126 via Activation of the Wnt/β-catenin Pathway", Project No: 81973620, Duration: January 2020 – December 2023.(Principal Investigator)
2. National Natural Science Foundation of China (NSFC) - General Program: "Role and Mechanism of the Wnt/Dvl/β-catenin Pathway in Adenosine A1 Receptor-Mediated Electroacupuncture-Induced Cerebral Ischemic Tolerance", Project No: 81774109, Duration: January 2018 – December 2021.(Principal Investigator)
3. National Natural Science Foundation of China (NSFC) - General Program: “Regulation of Adenosine A1 Receptor-Mediated Acupuncture Analgesia by the PICK1-ICA69 Complex”,Project No:81573742,Duration: January 2016 – December2019.(Co-Investigator)
4. National Natural Science Foundation of China (NSFC) - General Program:“Mechanism of adenosine signaling in electroacupuncture pretreatment-induced cerebral ischemic tolerance”,Project No:81273926, Duration: January 2013 – December2016.(Co-Investigator)
5. Zhejiang Provincial "Pioneer & Leading Goose + X" R&D Program (2024): "Research on Key Technologies for Tissue Damage Repair Based on Stem Cell Function", Project No: 2024SSYS0057, Duration: December 2023 – Present.(Principal Investigator)
6. Zhejiang Provincial Natural Science Foundation: "Mechanism of Electroacupuncture-Induced Cerebral Ischemic Tolerance Mediated by the Wnt Signaling Pathway", Project No: LY15H270014, Duration: January 2015 – December 2017.(Principal Investigator)
7. Wenzhou Municipal Science and Technology Bureau Major Project: "Research on Early Warning, Diagnosis, and Treatment Technologies for Critical Illnesses", Project No.: ZY2024026, Duration: June 2024 – May 2027.(Principal Investigator)
1. Yiyang Zheng#, Yanyan Luo , Xixi Chen, Huiting Li, Baojun Huang, Baofeng Zhou, Liqing Zhu*, Xianhui Kang* , Wujun Geng* .The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors.Mol Cancer. 2021 Mar 5;20(1):49（共同通讯作者）
2. Cheng-Cheng Wang #, Hong Peng #, Zi Wang, Jiao Yang, Rong-Gui Hu, Chuan-Yin Li* , Wu-Jun Geng* .TRIM72-mediated degradation of the short form of p62/SQSTM1 rheostatically controls selective autophagy in human cells.Mil Med Res. 2022 Jun 22;9(1):35.（共同通讯作者）
3..Sicheng Tang #, Wenchao Wang #, Yijian Wang, Yuhan Gao, Keke Dai, Wenjing Zhang, Xudong Wu, Xiaodie Yuan, Chaofan Jin, Xingjie Zan, Limeng Zhu, Wujun Geng*.Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy.Journal of Nanobiotechnology.2024 Aug 6;22(1):468.（通讯作者）
